dementia

shutterstock_189857270

Introduction

Dementia is a syndrome resulting from brain disease, characterised by a global cognitive decline, which may include disturbances of thinking, memory, comprehension and orientation.

Symptoms can vary, depending on the cause, but memory difficulties are often the first problem to be noticed. There is sometimes a change in personality with alterations in behaviour, termed ‘BPSD’ (behavioural and psychological symptoms of dementia).

There are several types of dementia. We could talk about each in much greater detail, but in summary the most prevalent types are:

  • Alzheimer’s disease (most common form of dementia)
  • Lewy body dementia
  • Vascular dementia
  • Frontotemporal dementia
  • Rarer causes e.g. HIV, vitamin B12 deficiency, etc

What we already know

Screening and diagnosis of dementia has much improved over the last few years, with many areas of the country having a specific ‘memory clinic’ service, although controversy remains about which instrument to use to diagnose dementia.

The management of dementia includes both pharmacological treatment and non-pharmacological considerations (e.g. ensuring the environment is appropriate, providing activity and stimulation and addressing communication needs).

The use of acetylcholinesterase inhibitors has become much more widespread over recent years and, although it is no wonder drug or cure, for some people with Alzheimer’s, it can slow the progression of the disease. NICE guidelines recommend the use of Donepezil, Galantamine or Rivastigmine for mild-moderate Alzheimer’s disease. Mematine is recommended as an option for those with moderate Alzheimer’s disease who cannot tolerate acetylcholinesterase inhibitors, or for those with severe Alzheimer’s disease.

Areas of uncertainty

What actually causes dementia? We know lots of factors and even some genetic changes that are associated with dementia but we know little about the actual direct causes of dementia.

There is also uncertainty about the reason that some people progress from Mild Cognitive Impairment (memory impairment that does not meet diagnostic threshold of dementia) to dementia and how to predict who this will happen to.

What’s in the pipeline

Media reports often hint at a progression towards finding a cure for dementia. In practice we may not be that close, but there are several areas that researchers are working on:

  • Gene therapy
  • A vaccine for dementia
  • The use of stem cells to develop replacement cells lost in dementia

References

Giebel, C. M., Sutcliffe, C., Stolt, M., Karlsson, S., Renom-Guiteras, A., Soto, M., … Challis, D. (2014). Deterioration of basic activities of daily living and their impact on quality of life across different cognitive stages of dementia: a European study. International Psychogeriatrics / IPA, 26(8), 1283–93. doi:10.1017/S1041610214000775 [Abstract]

NICE guidelines CG42 (2015) “Dementia: Supporting people with dementia and their carers in health and social care” [PDF]

Semple, D. and Smyth, R. (eds.) (2013) Oxford Handbook of Psychiatry. 3rd ed. Oxford: Oxford University Press. [Publisher]

Acknowledgement

Written by: Josephine Neale
Reviewed by:
Last updated: Sep 2015
Review due: Sep 2016

Our dementia Blogs

Survivors of genocide more likely to develop dementia, according to new Israeli study

andrea-nardi-mtJUCgwxBH4-unsplash

Anna Sri explores a recent Israeli study which suggests that people exposed to genocide are more likely to develop dementia, even when a range of confounders are accounted for.

[read the full story...]

STrAtegies for RelaTives (START): long-lasting effect on the wellbeing of family carers of dementia patients

dario-valenzuela-PAGBeJrLiDA-unsplash

A group of UCL Mental Health MSc students summarise a recent RCT assessing the clinical and cost-effectiveness over 6 years of the START intervention for family carers of people with dementia.

[read the full story...]

Personalised medicine: a transformative era in dementia research

ravi-patel-VMGAbeeJTKo-unsplash

Nagina Khan writes her debut elf blog on a recent study in the British Journal of Psychiatry about the individual course of neuropsychiatric symptoms in people with Alzheimer’s and Lewy body dementia.

[read the full story...]

Too much TV is associated with decline in verbal memory

1

Sarah Gregory summarises findings from a large dataset analysis which explores the relationship between watching television and later cognitive decline.

[read the full story...]

MARQUE training to reduce agitation in dementia in care homes

shutterstock_1470511052

A group of UCL Mental Health Masters students summarise an RCT on the clinical and cost-effectiveness of the MARQUE intervention (Managing Agitation and Raising Quality of Life) for agitation in people with dementia in care homes.

[read the full story...]

Review of apps and other digital technology to assess cognition in older adults

shutterstock_1456628195

Sarah Gregory writes her debut elf blog on a clinical review in the Evidence-Based Mental Health journal about digital technologies for the assessment of cognition.

[read the full story...]

End of life dementia care: helping people live well and die well

annie-spratt-7-vwc5XvkCs-unsplash

A group of UCL Mental Health MSc students summarise a recent clinical review of the challenges we face in providing end of life dementia care.

[read the full story...]

New genes implicated in Alzheimer’s disease #LetsTalkMentalHealthII

victor-vorontsov-528554-unsplash

Byron Creese writes a #LetsTalkMentalHealthII blog about a recent genome-wide meta-analysis which identifies new loci and functional pathways influencing Alzheimer’s disease risk.

[read the full story...]

The costs of care prior to institutionalisation among people living with Alzheimer’s disease

11180356596_99cd1af01c_o

The past few decades have seen a gradual shift of provision of services for older people from residential care to community-based care in the UK and other high-income countries. ‘Ageing in place’ is a widely accepted and supported discourse. In practice, receiving care at home enables older people to stay in a familiar environment, and [read the full story…]

Advance care planning in dementia nursing homes with family carers

Josie Dixon considers a paired-cluster randomised controlled trial of an advance care planning intervention, called the Family Carer Decision Support (FCDS) intervention, undertaken by Kevin Brazil and colleagues (2018) in dementia nursing homes.

[read the full story...]